This retrospective observational study evaluates the efficacy of periarticular vasoconstrictor infiltration (PVI) in reducing intraoperative bleeding and postoperative pain in adult patients undergoing lumbar fusion surgery at Hospital de la Santa Creu i Sant Pau (Barcelona, Spain) from November 2024 to October 2025. PVI, introduced recently as an alternative to erector spinae plane (ESP) block, involves ultrasound-guided infiltration of local anesthetic with epinephrine in deep and superficial periarticular planes before surgery. The study includes all consecutive cases meeting inclusion criteria (lumbar fusion in adults), excluding incomplete records (expected n=25).
Lumbar fusion surgery treats degenerative disc disease, spondylolisthesis, and lumbar stenosis when conservative management fails. It carries high risks of intraoperative bleeding (often requiring transfusion) and severe postoperative pain necessitating systemic opioids, impacting patient safety and recovery. Multimodal pain management and bleeding control are key challenges. Periarticular vasoconstrictor infiltration (PVI), inspired by tumescent anesthesia and WALANT techniques, has shown promise in reducing bleeding and improving analgesia in other orthopedic procedures. At Hospital de la Santa Creu i Sant Pau (Barcelona, Spain), PVI-ultrasound-guided infiltration of local anesthetic with epinephrine in deep/superficial periarticular planes was recently adopted preoperatively, replacing erector spinae plane (ESP) block, with promising clinical outcomes lacking formal retrospective analysis
Study Type
OBSERVATIONAL
Enrollment
25
Ultrasound-guided infiltration of local anesthetic and epinephrine in deep and superficial periarticular planes before lumbar fusion surgery, as part of routine clinical care.
Hospital de La Santa Creu I Sant Pau
Barcelona, BARCELONA, Spain
Intraoperative blood loss
Total volume aspirated (mL) from surgical suction, minus irrigation volume
Time frame: Perioperative
Postoperative pain intensity
Numeric Verbal Scale (0-10) at 24 hours
Time frame: up to 24 hours
Postoperative opioid consumption
Total systemic opioid dose administered postoperatively
Time frame: up to 24 hours
Opioid-related adverse effects
Incidence of nausea, vomiting, constipation, or sedation related to postoperative opioid use
Time frame: up to 24 hours
Drain output
Total postoperative drain output (mL) recorded in surgical drains
Time frame: Perioperative
Need for blood transfusion
Proportion of patients requiring perioperative red blood cell transfusion
Time frame: Perioperative
Length of hospital stay
Number of days from surgery to hospital discharge
Time frame: Perioperative
Block-related and postoperative complications
Incidence of complications related to PVI or surgery (e.g., hypertension, arrhythmias, wound infection, hematoma, reoperation)
Time frame: Perioperarive
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.